Clinical Trials Related to Solid Tumors

Related studies linked through entity extraction aliases.

A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors with Resectable Disease with Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)

Status: WITHDRAWN
Phase: PHASE2

Spatial Profile of Tumors

Status: NOT_YET_RECRUITING
Phase: N/A

Phase I Trial of Combined Immune Cell Therapy for Metastatic Stage IV Solid Tumors (SDH-Combi)

Status: COMPLETED
Phase: PHASE1

A Study of ZG005 in Patients With Advanced Solid Tumors

Status: RECRUITING
Phase: PHASE1/PHASE2

QTX3034 in Patients With KRAS G12D Mutation

Status: RECRUITING
Phase: PHASE1

CTS2190 Phase I /II Clinical Study in Patients

Status: RECRUITING
Phase: PHASE1/PHASE2

BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Status: RECRUITING
Phase: PHASE1

A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home

Status: COMPLETED
Phase: N/A

A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)

Status: RECRUITING
Phase: PHASE1

Sacituzumab Tirumotecan (MK-2870) as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors (MK-2870-008)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of ADRX-0706 in Select Advanced Solid Tumors

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck Cancer

Status: RECRUITING
Phase: PHASE1

Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors

Status: RECRUITING
Phase: PHASE1

A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Expanded Access to Telisotuzumab Adizutecan

Status: AVAILABLE
Phase: N/A

An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

Status: TERMINATED
Phase: PHASE1

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Status: WITHDRAWN
Phase: PHASE1